Trials / Completed
CompletedNCT01178086
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Rituximab in the Treatment of Chronic Lymphocytic Leukemia, "CLL NIS"
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 681 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study will assess the therapeutic efficiency, treatment schedules, handling procedures, and the safety profile of rituximab in routine care in participants with CLL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab | Rituximab IV |
Timeline
- Start date
- 2010-02-22
- Primary completion
- 2015-06-30
- Completion
- 2015-06-30
- First posted
- 2010-08-09
- Last updated
- 2018-10-05
- Results posted
- 2018-10-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01178086. Inclusion in this directory is not an endorsement.